Narcotic and psychotropic drugs: Achieving balance in national opioids control: Guidelines for assessment (WHO/EDM, 2000, 41 p.): ACKNOWLEDGMENTS

Narcotic and psychotropic drugs: Achieving balance in national opioids control: Guidelines for assessment (WHO/EDM, 2000, 41 p.)

		(introductory text...)
		EXECUTIVE SUMMARY
		SECTION I - PURPOSE AND AUDIENCE
		SECTION II - INADEQUATE PAIN RELIEF
		SECTION III - MEDICAL NEED FOR OPIOID ANALGESICS
		SECTION IV - THE INADEQUATE AVAILABILITY OF OPIOIDS
		SECTION V - IMPEDIMENTS TO OPIOID AVAILABILITY
		SECTION VI - THE IMPERATIVE TO EVALUATE NATIONAL DRUG CONTROL POLICY
		SECTION VII - METHOD FOR PREPARING THE GUIDELINES
		SECTION VIII - USING THE GUIDELINES
		SECTION IX - THE GUIDELINES
		SECTION X - SELF-ASSESSMENT CHECKLIST
		ACKNOWLEDGMENTS
		REFERENCES
		ANNEX 1 - USE OF TERMS IN THIS DOCUMENT
		ANNEX 2 - ORDERING INFORMATION FOR KEY RESOURCES
		ANNEX 3 - SUMMARY OF THE GUIDELINES
		ANNEX 4 - GLOBAL CONSUMPTION OF PRINCIPAL NARCOTIC DRUGS

ACKNOWLEDGMENTS

The World Health Organization wishes to acknowledge the assistance of the World Health Organization Collaborating Centre for Policy and Communications in Cancer Care, Pain & Policy Studies Group, University of Wisconsin, Comprehensive Cancer Center (Madison, Wisconsin, USA). The following staff of the Collaborating Centre prepared the initial drafts of this document and hosted the meeting of the working group to review the document: Mr D.E. Joranson, Senior Scientist and Director; Dr A.M. Gilson, Researcher for Policy Studies; Ms K.M. Ryan, Policy Analyst; and Ms M.A. Maurer, Associate Research Specialist. For more information on this WHO Collaborating Centre, refer to the Pain & Policy Studies Group website at http://www.medsch.wisc.edu/painpolicy.

Listed below are the participants in the WHO Working Group, held in Madison, Wisconsin, USA, 22-24 November 1999:

Mr R. Bhattacharji, Narcotics Commissioner of India, Gwalior, India

Dr C. Blengini, General Practitioner; Member, Special Committees of Italian Ministry of Health on Pain and Palliative Care, Cuneo, Italy

Dra. L. De Lima, Consultant, Pan American Health Organization, Houston, Texas, USA

Dr P. Emafo, Expert, World Health Organization Expert Advisory Panel for Drug Dependence; Member-elect, International Narcotics Control Board, Benin City, Nigeria

Ms Gu Weiping, Director, Department of Drug Safety and Inspections, State Drug Administration, Beijing, China

Mr D. Joranson, Director, World Health Organization Collaborating Centre for Policy and Communications in Cancer Care, Pain & Policy Studies Group, University of Wisconsin, Madison, Wisconsin, USA (Chair)

Dr A. Nixon, Head of Palliative Care Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Ms C. Selva, Chief, Estimates Unit, International Narcotics Control Board secretariat, United Nations, Vienna, Austria

WHO Secretariat

Mr T. Yoshida, Quality Assurance & Safety: Medicines, Essential Drugs and Medicines Policy